On November 20, 2018 CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three upcoming investor conferences: the Piper Jaffray 30th Annual Healthcare Conference, the Evercore ISI HealthCONx Conference, and the BMO Prescriptions for Success Conference (Press release, CymaBay Therapeutics, NOV 20, 2018, View Source [SID1234531499]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Piper Jaffray 30th Annual Healthcare Conference
Date: Tuesday, November 27
Time: 12:00pm Eastern Time
Location: Lotte New York Palace Hotel
Evercore ISI HealthCONx Conference
Date: Wednesday, November 28
Time: 9:05am Eastern Time
Location: Boston Harbor Hotel
BMO Prescriptions for Success Conference
Date: Wednesday, December 12
Time: 11:40am Eastern Time
Location: Mandarin Oriental NYC
To access a live webcast and subsequent archived recording of each presentation, please visit the "Events" section on the CymaBay website at View Source